Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 1, 1989
Piperacillin for prophylaxis in gynecological surgery
J B Trimbos, A C van Lindert, A P Heintz, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 18, 1982
[Contamination with rubella virus in pregnancy]
M H Houwert-de Jong, A C van Lindert, G P Alsbach, et al.
Gynecologic Oncology
|
September 1, 1996
Epidemiologic data on vulvar cancer: comparison of hospital with population-based data
J van der Velden, A C van Lindert, C H Gimbrere, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 1, 1987
A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy
P F van Bommel, A C van Lindert, H C Kock, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 20, 1980
[Chemotherapy of stage III and IV ovarian carcinoma]
J P Neijt, J W Barents, C P Vendrik, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Cytoreductive surgery with or without preceding chemotherapy in ovarian cancer
J P Neijt, E J Aartsen, J Bouma, et al.
Cancer Treatment Reports
|
February 1, 1980
Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment
J P Neijt, A C van Lindert, C P Vendrik, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
July 1, 1990
Single-dose prophylaxis with broad-spectrum penicillins (piperacillin and mezlocillin) in gynecologic oncological surgery, with observation on serum and tissue concentrations
A C van Lindert, A R Giltaij, M D Derksen, et al.
European Journal of Gynaecological Oncology
|
January 1, 1988
The role of cytoreduction in ovarian cancer
F Zanaboni, A P Heintz, J B Trimbos, et al.
The Netherlands Journal of Medicine
|
January 1, 1979
Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future
J P Neijt, A C van Lindert, C P Vendrik, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 1, 1989
Piperacillin for prophylaxis in gynecological surgery
J B Trimbos, A C van Lindert, A P Heintz, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 18, 1982
[Contamination with rubella virus in pregnancy]
M H Houwert-de Jong, A C van Lindert, G P Alsbach, et al.
Gynecologic Oncology
|
September 1, 1996
Epidemiologic data on vulvar cancer: comparison of hospital with population-based data
J van der Velden, A C van Lindert, C H Gimbrere, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 1, 1987
A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy
P F van Bommel, A C van Lindert, H C Kock, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 20, 1980
[Chemotherapy of stage III and IV ovarian carcinoma]
J P Neijt, J W Barents, C P Vendrik, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Cytoreductive surgery with or without preceding chemotherapy in ovarian cancer
J P Neijt, E J Aartsen, J Bouma, et al.
Cancer Treatment Reports
|
February 1, 1980
Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment
J P Neijt, A C van Lindert, C P Vendrik, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
July 1, 1990
Single-dose prophylaxis with broad-spectrum penicillins (piperacillin and mezlocillin) in gynecologic oncological surgery, with observation on serum and tissue concentrations
A C van Lindert, A R Giltaij, M D Derksen, et al.
European Journal of Gynaecological Oncology
|
January 1, 1988
The role of cytoreduction in ovarian cancer
F Zanaboni, A P Heintz, J B Trimbos, et al.
The Netherlands Journal of Medicine
|
January 1, 1979
Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future
J P Neijt, A C van Lindert, C P Vendrik, et al.
Page
of 3